Related Articles
HDAC6 promotes cell proliferation and confers resistance to gefitinib in lung adenocarcinoma
HDAC6‑selective inhibitor synergistically enhances the anticancer activity of immunomodulatory drugs in multiple myeloma
Survival of patients with cutaneous T-cell lymphoma after treatment with extracorporeal photochemotherapy.
Histone deacetylase 6 inhibition in urothelial cancer as a potential new strategy for cancer treatment
Utility of flow cytometry and gene rearrangement analysis in tissue and blood of patients with suspected cutaneous T‑cell lymphoma